Ready Player One?
Get in the game. Podium and poster abstracts are now being accepted for SLAS2020.
Board Director, BenevolentAI
Dr. Hunter has more than 30 years of experience in the bioscience research sector, working across academia and industry including leading neurology and gastrointestinal drug discovery and early clinical development for GlaxoSmithKline. She now leads BenevolentAI, which uses AI to augment the research capabilities of drug scientists, radically changing the way R&D is done -- from target identification and validation, through medicinal chemistry and lead optimization to clinical PoC.
Professor, University of Glasgow
With one of the largest multidisciplinary chemistry-based research teams in the world, Dr. Cronin’s group at the University of Glasgow is developing the concept of ‘Chemputing’ which enables the universal digitization of chemistry, in order to create artificial life forms, find alien life, further explore the digitization of chemistry, understand how information can be encoded into chemicals and construct chemical computers.